IL‐1β and IL‐17A are involved in IVIG resistance through activation of C/EBPβ and δ in a coronary artery model of Kawasaki disease
- 18 March 2020
- Vol. 75 (8), 2102-2105
- https://doi.org/10.1111/all.14281
Abstract
No abstract availableFunding Information
- Japan Agency for Medical Research and Development (JP18ak0101087)
- Japan Society for the Promotion of Science (23591666)
This publication has 9 references indexed in Scilit:
- Biomarkers of intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki diseaseWorld Journal of Pediatrics, 2019
- Inositol-Triphosphate 3-Kinase C Mediates Inflammasome Activation and Treatment Response in Kawasaki DiseaseThe Journal of Immunology, 2016
- Review: Found in Translation: International Initiatives Pursuing Interleukin‐1 Blockade for Treatment of Acute Kawasaki DiseaseArthritis & Rheumatology, 2016
- Th17‐ and Treg‐related cytokine and mRNA expression are associated with acute and resolving Kawasaki diseaseAllergy, 2015
- Anti‐inflammatory effects of high‐dose IgG on TNF‐α‐activated human coronary artery endothelial cellsEuropean Journal of Immunology, 2012
- Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistanceHuman Immunology, 2010
- The T helper type 17/regulatory T cell imbalance in patients with acute Kawasaki diseaseClinical and Experimental Immunology, 2010
- IL-1B Polymorphism in Association With Initial Intravenous Immunoglobulin Treatment Failure in Taiwanese Children With Kawasaki DiseaseCirculation Journal, 2010
- ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysmsNature Genetics, 2007